Treatment of vitamin D deficiency in CKD patients with ergocalciferol: Are current K/DOQI treatment guidelines adequate?

Medicine and Dentistry

• Patient 100%
• Ergocalciferol 90%
• Therapeutic Procedure 50%
• Parathyroid Hormone 40%
• Vitamin D Deficiency 40%
• 25 Hydroxyvitamin D 40%
• Potassium Current 20%
• Recommended Drug Dose 10%
• Secondary Hyperparathyroidism 10%
• Hyperparathyroidism 10%
• Phosphate Binder 10%
• Age 10%
• Clinical Endpoint 10%
• Male 10%
• Vitamin D 10%

Biochemistry, Genetics and Molecular Biology

• Ergocalciferol 90%
• Vitamin D 50%
• Mineral Metabolism 40%
• Retrospective Study 30%
• Potassium Current 20%
• Age 10%
• Phosphate 10%
• Recommended Drug Dose 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Ergocalciferol 90%
• Parathyroid Hormone 40%
• 25 Hydroxyvitamin D 40%
• Vitamin D Deficiency 40%
• Phosphate Binding Agent 10%
• Secondary Hyperparathyroidism 10%
• Hyperparathyroidism 10%
• Vitamin D 10%